Are you ready for the next generation of cell expansion? Automate the right way, right from the start with the Quantum Flex platform. Gain the flexibility, scalability and connectivity to grow with your therapy, from process development to clinical manufacturing.
Download a summary of Quantum Flex information.
The Quantum Flex platform facilitates lower seeding densities and reduces the need for manual preculture.1,2,3 A second bioreactor option (~1/10th the size) provides a scaled-down model ideal for process development and research, reducing time, risk and cost.
See the difference for suspension and adherent cells and small clinical batches in this infographic.
Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today.
It is the responsibility of the user to validate the safety and efficacy of the expanded cells for their intended application. Performance varies by user and is dependent on customer processes and materials.
* Seeding and yield numbers provided are for the large sized bioreactor.
1Data on file at Terumo Blood and Cell Technologies.
2Hanley PJ, Mei Z, Durett AG, et al. Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System. Cytotherapy. 2014;16(8):1048-1058.
3Nankervis B, Jones M, Vang B, Rice Jr BR, Coeshott C, Beltzer J. Optimizing T cell expansion in a hollow-fiber bioreactor. Curr Stem Cell Rep. 2018;4(1):46-51.
4Jones M, Nankervis B, Roballo KS, Pham H, Bushman J, Coeshott C. A comparison of automated perfusion- and manual diffusion-based human regulatory T cell expansion and functionality using a soluble activator complex. Cell Transplant. 2020;29:963689720923578.
5Coeshott C, Vang B, Jones M, Nankervis B. Large-scale expansion and characterization of CD3+ T-cells in the Quantum® Cell Expansion System. J Transl Med. 2019;17:258.
6Williams AM, Dennahy IS, Bhatti UF, et al. Mesenchymal stem cell-derived exosomes provide neuroprotection and improve long-term neurologic outcomes in a swine model of traumatic brain injury and hemorrhagic shock. J Neurotrauma. 2019;36(1):54-60.